Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 7.80
+0.08 (1.04%)
At close: Feb 11, 2026
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 1.14 billion as of February 11, 2026. Its market cap has decreased by -31.58% in one year.
Market Cap
1.14B
Enterprise Value
945.92M
Revenue
47.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.80
Market Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 1.14B, a decrease of -79.47%. That is a compound annual growth rate of -12.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.14B | 1.30% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.32B |
| Lukas Biomedical | 1.21B |
| GeneReach Biotechnology | 1.20B |
| Neith | 1.15B |
| Level Biotechnology | 1.06B |
| TCI GENE | 1.01B |